Phaarmasia Board of Directors
Get the latest insights into the leadership at Phaarmasia. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Maneesh Ramakant Sapte | Non Executive Director |
| Mr. Naga Bhaskara Rao Yallapragada | Whole Time Director |
| Mr. Vinay Ramakant Sapte | Non Executive Director |
| Mrs. Rashmi Vinay Sapte | Non Executive Director |
| Mr. Pravin Mohandas Hegde | Independent Director |
| Mr. Ajit Gopal Jamkhandikar | Independent Director |
Phaarmasia Share price
PHRMASI
32.4
1.52 (4.92%)Last updated on 3 Sep, 2025 | 15:21 IST
BUYSELL
Today's High
32.40
Today's Low
31.00
52 Week Low
23.60
52 Week High
64.53
The current prices are delayed, login to your account for live prices
LoginPhaarmasia FAQs
The board at Phaarmasia consists of experienced professionals, including Mr. Maneesh Ramakant Sapte , Mr. Naga Bhaskara Rao Yallapragada , and others, overseeing the company’s strategic and corporate governance.
Directors at Phaarmasia are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Maneesh Ramakant Sapte is the current chairman at Phaarmasia.
Executive directors at Phaarmasia are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Phaarmasia adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Phaarmasia, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.